BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells a potential adjuvant for infection control of immunodeficient patients
E. B. Oliveira S. M Thomazzi; J Rehder; EAntunes; Antonio Condino Neto; LAGID Meeting of the Autoimmunity in Primary Immunodeficiencies (12. 2007 São Paulo); BRAGID Meeting of the Autoimmunity in Primary Immunodeficiencies (1. 2007 São Paulo)
BAY 41-2272 increases phagocytosis by human THP-1 cells, neutrophils, and monocytes a potential new adjuvant for infection control in immunodeficient patients
P. V. S. Pereira A Falcai; W. C Aragão-Filho; J. B Frazão; O. C Marques; E. B Oliveira-Júnior; R. R Oliveira; P. R Errante; EAntunes; Antonio Condino Neto; LAGID Meeting of the Autoimmunity in Primary Immunodeficiencies (12. 2007 São Paulo); BRAGID Meeting of the Autoimmunity in Primary Immunodeficiencies (1. 2007 São Paulo)